NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC]
- Status
- TERMINATED
- Phase
- PHASE1
Salvage Docetaxel for Pretreated Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nab-Paclitaxel in High Risk Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.
- Status
- COMPLETED
- Phase
- PHASE3
An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations
- Status
- TERMINATED
- Phase
- PHASE2